Skip to main content

Table 1 Description of HPV detection in paired anal and oral swabs baseline and at follow-up (24 months after baseline)

From: Oral and anal high-risk human papilloma virus infection in HIV-positive men who have sex with men over a 24-month longitudinal study: complexity and vaccine implications

  Baseline oral HR-HPV n (%) Baseline oral non-HR-HPV n (%) Baseline oral neg n (%)
Baseline anal HR-HPV (77 pts) 7 (9.1) 15 (19.5) 55 (71.4)
Baseline anal non-HR HPV (20 pts) 1 (5) 4 (20) 15 (75)
Baseline anal neg (9 pts) 2 (22.2) 1 (11.1) 6 (66.7)
  Follow-up oral HR-HPV n (%) Follow-up oral non-HR-HPV n (%) Follow-up oral neg n (%)
Follow-up anal HR-HPV (101 pts) 8 (7.9) 17 (16.8) 76 (75.2)
Follow-up anal non-HR-HPV (44 pts) 3 (6.8) 9 (20.5) 32 (72.7)
Follow-up anal neg (17 pts) 0 0 17 (100)
  1. HR: high risk HPV genotypes
  2. non-HR: only not high risk HPV genotypes
  3. HPV: Human papillomavirus
  4. pts: patients